LGALS1, for instance, has been implicated in several hallmark features of glioblastoma pathogenesis, including resistance to chemoradiotherapy, induction of neo-angiogenesis, and suppression of anti-tumour immune responses [20]. This evidence concerns the gene LGALS1 and neoplasm.